Comment #3

MADDOG10 — Fri, 05 May 2023 16:57:46 GMT

These people are trying to kill us from within!

Comment #2

grwurston — Thu, 04 May 2023 22:58:40 GMT

<br />What is the mortality rate of remdesivir for Ebola patients?<br />The mean age of enrolled patients was 29 years and 56% of patients were women (6% of whom were pregnant). At day 28, mortality rates were: remdesivir (53.1%), ZMapp (49.7%), MAb114 (35.1%), and REGN-EB3 (33.5%).

Comment #1

eddessaknight — Thu, 04 May 2023 22:27:33 GMT

Cash Cows :-(

Original Blog Entry: Here We Go Again

grwurston — Thu, 04 May 2023 22:20:16 GMT

Another new vaccine (RSV) that is effective for only 2 months and has serious side effects, for an illness most people have already had. From a company (GSK) that has millions of doses ready to be shipped before it was even FDA approved. And is expected to make $10 billion by 2030.

From the article: During clinical trials for both the GSK and Pfizer vaccines , several participants were diagnosed with rare conditions such as Guillain-Barr syndrome (GBS) and acute disseminated encephalomyelitis (ADEM). One of the individuals who developed ADEM later died, according to the FDA.

Further down in the article: Nevertheless, more RSV vaccines are expected to receive FDA approval this year including a Pfizer RSV vaccine for pregnant women that led to a high incidence of adverse events for both the women and their infants during clinical trials, as well as several deaths and stillbirths.

I am 100% certain every one of the MSM outlets will be telling us how safe and effective it is. They must think we're stupid.

Please read the entire article.

https://childrenshealthdefense.org/defender/fda-approves-rsv-vaccine-arexvy/... [ More ]